Joanie Thelen

Joanie Thelen

Auto-generated profile, based on publicly available information

Joanie Thelen

Department of Psychology, University of Missouri-Kansas City, Kansas City, MO, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2017 in Depression and Anxiety
Verified
Journal Article
Closed access
PDF file
ACAshley Clausen
Ashley Clausen
AFAlex J. Francisco
Alex J. Francisco
JTJoan Thelen
Joan Thelen
JBJared Bruce
Jared Bruce
LMLaura E. Martin
Laura E. Martin
RARobin L. Aupperle
Robin L. Aupperle

1 May 2014 in Journal of Psychosomatic Research
Verified
Journal Article
Closed access
JTJoanie M Thelen
Joanie M Thelen
SLSharon G Lynch
Sharon G Lynch
ABAmanda S Bruce
Amanda S Bruce
LHLaura M Hancock
Laura M Hancock
JBJared M Bruce
Jared M Bruce

1 April 2021 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Closed access
SLSharon G Lynch
Sharon G Lynch
SBSara Baker
Sara Baker
MNMuhammad Nashatizadeh
Muhammad Nashatizadeh
ATAmanda Thuringer
Amanda Thuringer
JTJoan Thelen
Joan Thelen
JBJared Bruce
Jared Bruce

12 November 2015 in Journal of Behavioral Medicine
Verified
Journal Article
Closed access
PDF file
JBJared Bruce
Jared Bruce
ABAmanda Bruce
Amanda Bruce
SLSharon Lynch
Sharon Lynch
LSLauren Strober
Lauren Strober
SOSean O’bRyan
Sean O’bRyan
DCDelwyn Catley
Delwyn Catley

22 September 2018 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
JBJared M. Bruce
Jared M. Bruce
ABAmanda S. Bruce
Amanda S. Bruce
SLSharon Lynch
Sharon Lynch
JTJoanie Thelen
Joanie Thelen
SLSeung-Lark Lim
Seung-Lark Lim
DJDavid P. Jarmolowicz
David P. Jarmolowicz

1 March 2019 in Frontiers in Psychiatry
Verified
Journal Article
Open access
PDF file
ACAshley Clausen
Ashley Clausen
JTJoan Thelen
Joan Thelen
AFAlex J. Francisco
Alex J. Francisco
JBJared Bruce
Jared Bruce
LMLaura Martin
Laura Martin
RARobin L. Aupperle
Robin L. Aupperle
Background: While evidence-based PTSD treatments are often efficacious, 20–50% of individuals continue to experience significant symptoms following treatment. Further, these treatments do not directly target associated neuropsychological deficits. Here, we describe the methods and feasibility for computer-based executive function training (EFT), a potential alternative or adjunctive PTSD treatment. Methods: Male combat veterans with full or partial PTSD (n = 20) and combat-exposed controls (used for normative comparison; n = 20) completed clinical, neuropsychological and functional neuroimaging assessments. Those with PTSD were assigned to EFT (n = 13) or placebo training (word games; n = 7) at home for 6 weeks, followed by repeat assessment. Baseline predictors of treatment completion were explored using logistic regressions. Individual feedback and changes in clinical symptoms, neuropsychological function, and neural activation patterns are described. Results: Dropout rates for EFT and placebo training were 38.5 and 57.1%, respectively. Baseline clinical severity and brain activation (i.e., prefrontal-insula-amygdala networks) during an emotional anticipation task were predictive of treatment completion. Decreases in clinical symptoms were observed following treatment in both groups. EFT participants improved on training tasks but not on traditional neuropsychological assessments. All training completers indicated liking EFT, and indicated they would engage in EFT (alone or as adjunctive treatment) if offered. Conclusion: Results provide an initial framework to explore the feasibility of placebo-controlled, computerized, home-based executive function training (EFT) on psychological and neuropsychological function and brain activation in combat veterans with PTSD. Clinical severity and neural reactivity to emotional stimuli may indicate which veterans will complete home-based computerized interventions. While EFT may serve as a potential alternative or adjunctive PTSD treatment, further research is warranted to address compliance and determine whether EFT may benefit functioning above and beyond placebo interventions.